Integrated Research Valuation
| IREHF Stock | USD 0.21 0.00 0.00% |
Integrated Research seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Integrated Research from evaluating the firm fundamentals such as Return On Asset of -0.0351, return on equity of 0.0181, and Current Valuation of 49.44 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Integrated Research's price fluctuation is out of control at this time. Calculation of the real value of Integrated Research is based on 3 months time horizon. Increasing Integrated Research's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Integrated pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Integrated Research Limited. Since Integrated Research is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Integrated Pink Sheet. However, Integrated Research's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.21 | Real 0.18 | Hype 0.21 | Naive 0.21 |
The real value of Integrated Pink Sheet, also known as its intrinsic value, is the underlying worth of Integrated Research Company, which is reflected in its stock price. It is based on Integrated Research's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Integrated Research's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Integrated Research Limited helps investors to forecast how Integrated pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Integrated Research more accurately as focusing exclusively on Integrated Research's fundamentals will not take into account other important factors: Integrated Research Total Value Analysis
Integrated Research Limited is currently forecasted to have takeover price of 49.44 M with market capitalization of 69.61 M, debt of 11.19 M, and cash on hands of 14.93 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Integrated Research fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
49.44 M | 69.61 M | 11.19 M | 14.93 M |
Integrated Research Investor Information
About 34.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Integrated Research last dividend was issued on the 2nd of September 2020. Integrated Research Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Integrated Research Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Integrated Research has an asset utilization ratio of 50.52 percent. This implies that the Company is making $0.51 for each dollar of assets. An increasing asset utilization means that Integrated Research Limited is more efficient with each dollar of assets it utilizes for everyday operations.Integrated Research Ownership Allocation
Integrated Research Limited has a total of 172.96 Million outstanding shares. Integrated Research secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Integrated Research Profitability Analysis
The company reported the revenue of 62.87 M. Net Income was 1.54 M with profit before overhead, payroll, taxes, and interest of 62.87 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Integrated Research's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Integrated Research and how it compares across the competition.
About Integrated Research Valuation
The pink sheet valuation mechanism determines Integrated Research's current worth on a weekly basis. Our valuation model uses a comparative analysis of Integrated Research. We calculate exposure to Integrated Research's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Integrated Research's related companies.Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company was incorporated in 1988 and is based in North Sydney, Australia. Integrated Research operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 224 people.
8 Steps to conduct Integrated Research's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Integrated Research's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Integrated Research's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Integrated Research's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Integrated Research's revenue streams: Identify Integrated Research's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Integrated Research's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Integrated Research's growth potential: Evaluate Integrated Research's management, business model, and growth potential.
- Determine Integrated Research's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Integrated Research's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Integrated Research Growth Indicators
Investing in growth stocks can be very risky. If the company such as Integrated Research does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 172.5 M | |
| Quarterly Earnings Growth Y O Y | 13.756 | |
| Forward Price Earnings | 11.1732 | |
| Retained Earnings | 78.8 M |
Complementary Tools for Integrated Pink Sheet analysis
When running Integrated Research's price analysis, check to measure Integrated Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Research is operating at the current time. Most of Integrated Research's value examination focuses on studying past and present price action to predict the probability of Integrated Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Research's price. Additionally, you may evaluate how the addition of Integrated Research to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |